Music News

Blink-182 Announce ‘One More Time!’ 2024 North American Tour: See the Dates

Pierce The Veil will join the trek as a special guest.



Rory Kramer*

Blink-182 is returning to North America one more time. Just days after the release of the trio’s new album, Mark Hoppus, Tom DeLonge and Travis Barker have announced plans to bring their new songs on the road in North America next year.

Tickets for the One More Time Tour — named after the band’s Oct. 20 album — will go on sale this Friday, Oct. 27, at 10 a.m. local time for each venue. The trek will kick off June 20 in Orlando, after which the rock group will make stops at both stadiums and arenas across the United States. The leg will end with one show in Canada; Aug. 15 at Rogers Centre in Toronto. Billboard Canada Ed. Note: That lone Canadian date also features reunited Ontario post-hardcore heroes Alexisonfire in their lone support date of the tour. - Richard Trapunski


Produced by Live Nation, the band’s 30-date North American tour features a hometown performance at Petco Park in San Diego as well as shows at SoFi Stadium in Los Angeles, Citi Field in New York, Fenway Park in Boston, and more. Blink also has dates scheduled in Australia, New Zealand, Peru and Mexico throughout the first half of 2024.

Pierce The Veil, a fellow rock band native to San Diego, will join the North American leg as a special guest.

The tour announcement ties a bow on an exciting year for the “All The Small Things” musicians, who announced in October last year that DeLonge would be reinstated as part of the band. The singer/guitarist had previously left the group twice, once in 2005 and again in 2014. Their new album One More Time… marked the first time Blink’s classic lineup had been in the studio together in a decade and features 17 Barker-produced tracks, including Alternative Airplay No. 1s “Edging” and “One More Time.”


See the announcement, which contains the full list of tour dates, below.

Hipgnosis Songs Fund Agrees $1.4B Sale to Concord Chorus

Hipgnosis Songs Fund Agrees $1.4B Sale to Concord Chorus

The deal values each Hipgnosis share at £0.93, a premium of roughly one third the royalty fund's shareprice at the close of trading on Wednesday.

The troubled music royalty company Hipgnosis Songs Fund (HSF) has agreed to a $1.402 billion takeover bid from Nashville-based rival Concord, according to a filing made Thursday (April 18) to the London Stock Exchange.

The deal values each Hipgnosis share at £0.93, a premium of roughly one third the fund’s closing shareprice on Wednesday, and shareholders controlling nearly 30% of the company are supporting it, according to the filing. Hipgnosis Songs Fund’s assets include stakes in songs by Neil Young, Justin Bieber, Journey, Lindsey Buckingham, Blondie and Justin Timberlake, among others.

keep readingShow less